moxonidine has been researched along with Arrhythmias, Cardiac in 7 studies
moxonidine: structure given in first source
Arrhythmias, Cardiac: Any disturbances of the normal rhythmic beating of the heart or MYOCARDIAL CONTRACTION. Cardiac arrhythmias can be classified by the abnormalities in HEART RATE, disorders of electrical impulse generation, or impulse conduction.
Excerpt | Relevance | Reference |
---|---|---|
"We previously reported that imidazoline receptors in the central nervous system are involved in modulation of halothane-epinephrine arrhythmias." | 7.73 | Identification of the central imidazoline receptor subtype involved in modulation of halothane-epinephrine arrhythmias in rats. ( Hayashi, Y; Itoh, I; Iwasaki, M; Kagawa, K; Kamibayashi, T; Mashimo, T; Takada, K; Yamatodani, A, 2005) |
" Due to the important role of the sympathetic nervous system in the genesis of neurogenic cardiac arrhythmias, we investigated the antiarrhythmic effects of moxonidine and compared them to those of propranolol in an experimental model of neurogenic arrhythmias." | 7.70 | Protective effects of I(1)-antihypertensive agent moxonidine against neurogenic cardiac arrhythmias in halothane-anesthetized rabbits. ( Christen, MO; Poisson, D; Sannajust, F, 2000) |
"The aim of the present study was to investigate the influence of moxonidine, a representative of I1-imidazoline-receptor agonist, on arrhythmias induced by myocardial ischemia or reperfusion." | 7.69 | Effect of moxonidine on arrhythmias induced by coronary artery occlusion and reperfusion. ( Leprán, I; Papp, JG, 1994) |
" In the first experiment the threshold dose of ouabain needed to induce ventricular arrhythmia and asystole was determined in guinea pigs, and the influence of moxonidine was tested." | 7.69 | Antiarrhythmic effect of the selective I1-imidazoline receptor modulator moxonidine on ouabain-induced cardiac arrhythmia in guinea pigs. ( Mest, HJ; Raap, A; Thomsen, P, 1995) |
"We previously reported that imidazoline receptors in the central nervous system are involved in modulation of halothane-epinephrine arrhythmias." | 3.73 | Identification of the central imidazoline receptor subtype involved in modulation of halothane-epinephrine arrhythmias in rats. ( Hayashi, Y; Itoh, I; Iwasaki, M; Kagawa, K; Kamibayashi, T; Mashimo, T; Takada, K; Yamatodani, A, 2005) |
" Due to the important role of the sympathetic nervous system in the genesis of neurogenic cardiac arrhythmias, we investigated the antiarrhythmic effects of moxonidine and compared them to those of propranolol in an experimental model of neurogenic arrhythmias." | 3.70 | Protective effects of I(1)-antihypertensive agent moxonidine against neurogenic cardiac arrhythmias in halothane-anesthetized rabbits. ( Christen, MO; Poisson, D; Sannajust, F, 2000) |
"The aim of the present study was to investigate the influence of moxonidine, a representative of I1-imidazoline-receptor agonist, on arrhythmias induced by myocardial ischemia or reperfusion." | 3.69 | Effect of moxonidine on arrhythmias induced by coronary artery occlusion and reperfusion. ( Leprán, I; Papp, JG, 1994) |
" In the first experiment the threshold dose of ouabain needed to induce ventricular arrhythmia and asystole was determined in guinea pigs, and the influence of moxonidine was tested." | 3.69 | Antiarrhythmic effect of the selective I1-imidazoline receptor modulator moxonidine on ouabain-induced cardiac arrhythmia in guinea pigs. ( Mest, HJ; Raap, A; Thomsen, P, 1995) |
"Moxonidine has been shown to be antiarrhythmic during ischaemia in vivo." | 1.30 | Facilitation of spontaneous defibrillation by moxonidine during regional ischaemia in an isolated working rabbit heart model. ( Cobbe, SM; Hicks, MN; Kane, KA; Wolk, R, 1999) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (71.43) | 18.2507 |
2000's | 2 (28.57) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kagawa, K | 1 |
Hayashi, Y | 1 |
Itoh, I | 1 |
Iwasaki, M | 1 |
Takada, K | 1 |
Kamibayashi, T | 1 |
Yamatodani, A | 1 |
Mashimo, T | 1 |
Leprán, I | 1 |
Papp, JG | 1 |
Mest, HJ | 1 |
Thomsen, P | 1 |
Raap, A | 1 |
Lada, W | 1 |
Wolk, R | 1 |
Kane, KA | 1 |
Cobbe, SM | 1 |
Hicks, MN | 1 |
Bousquet, P | 1 |
Feldman, J | 1 |
Poisson, D | 1 |
Christen, MO | 1 |
Sannajust, F | 1 |
2 reviews available for moxonidine and Arrhythmias, Cardiac
Article | Year |
---|---|
[Imidazoline receptors and use of drug blocking receptors I1].
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Antihypertensive Agents; Arrhythmias, Cardi | 1996 |
Drugs acting on imidazoline receptors: a review of their pharmacology, their use in blood pressure control and their potential interest in cardioprotection.
Topics: Animals; Antihypertensive Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Heart Failure; Hum | 1999 |
5 other studies available for moxonidine and Arrhythmias, Cardiac
Article | Year |
---|---|
Identification of the central imidazoline receptor subtype involved in modulation of halothane-epinephrine arrhythmias in rats.
Topics: Animals; Arrhythmias, Cardiac; Benzofurans; Blood Pressure; Dose-Response Relationship, Drug; Epinep | 2005 |
Effect of moxonidine on arrhythmias induced by coronary artery occlusion and reperfusion.
Topics: Analysis of Variance; Animals; Antihypertensive Agents; Arrhythmias, Cardiac; Coronary Vessels; Dise | 1994 |
Antiarrhythmic effect of the selective I1-imidazoline receptor modulator moxonidine on ouabain-induced cardiac arrhythmia in guinea pigs.
Topics: Aconitine; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-2 Receptor Antagonists; Animals | 1995 |
Facilitation of spontaneous defibrillation by moxonidine during regional ischaemia in an isolated working rabbit heart model.
Topics: Action Potentials; Animals; Antihypertensive Agents; Arrhythmias, Cardiac; Disease Models, Animal; E | 1999 |
Protective effects of I(1)-antihypertensive agent moxonidine against neurogenic cardiac arrhythmias in halothane-anesthetized rabbits.
Topics: Anesthesia; Animals; Anti-Arrhythmia Agents; Antihypertensive Agents; Arrhythmias, Cardiac; Blood Pr | 2000 |